Arash Rezazadeh Kalebasty

1 month ago | bjui-journals.onlinelibrary.wiley.com | David Benjamin |Arash Rezazadeh Kalebasty

Comment Precision medicine in genitourinary oncology: are we pivoting towards imprecision? David J. Benjamin,  Corresponding Author David J. Benjamin Hoag Family Cancer Institute, Newport Beach, CA, USA Correspondence: David J. Benjamin, Hoag Family Cancer Institute, 1 Hoag Drive, Building 41, Newport Beach, CA 92663, USA.

Mar 29, 2025 | journals.sagepub.com | Parnian Jabbari |Omid Yazdanpanah |David Benjamin |Arash Rezazadeh Kalebasty

IntroductionMaintaining health and longevity has been an age-old concern of mankind. Careful observations led to the discovery of the relationship between certain practices and natural compounds and improved health. These discoveries led to the formation of various systems of medicine across different geographic regions, long before the advent of allopathic medicine.1 One such system is Ayurvedic medicine.

Oct 31, 2024 | bjui-journals.onlinelibrary.wiley.com | David Benjamin |Anshu Shrestha |Arash Rezazadeh Kalebasty |Dimitra Fellman

1 INTRODUCTION The incidence of testicular cancer has been rising globally among young adult men for the past five decades for reasons not currently well-understood.1 Although a rare genitourinary malignancy that is generally curable, testicular cancer remains a significant public health concern due to long-term medical, psychological and social burden associated with treatment and its short- and long-term toxicities.2 Risk factors leading to the development of testicular cancer include age,...

Oct 4, 2024 | jnm.snmjournals.org | Jérémie Calais |Michael Morris |Ayse Tuba Kendi |Arash Rezazadeh Kalebasty

BEST PRACTICES FOR AE MANAGEMENTThe safety of [177Lu]Lu-PSMA-617 in patients with mCRPC has been established in the phase III VISION study (3,7) and the phase II studies TheraP and RESIST-PC (8,9). In the VISION study, the most commonly reported AEs with [177Lu]Lu-PSMA-617 treatment were fatigue, dry mouth, nausea, and anemia (Supplemental Table 1; supplemental materials are available at http://jnm.snmjournals.org) (3), generally consistent with reports from TheraP (8) and RESIST-PC (9).

May 14, 2024 | bjui-journals.onlinelibrary.wiley.com | David Benjamin |Omid Yazdanpanah |Arash Rezazadeh Kalebasty

Research Letter A review of vitamin use for the prevention or treatment of prostate cancer David J. Benjamin,  Corresponding Author David J. Benjamin Hoag Family Cancer Institute, Newport Beach, CA, USA Correspondence: David J. Benjamin, Hoag Family Cancer Institute, 1 Hoag Drive, Building 41, Newport Beach, CA 92663, USA.